top of page

PEAL Capital Fund Investment

1 May 2022

Female-founded private equity firm PEAL Capital Group acquires majority shareholding in leading aesthetic training provider Derma Medical

LONDON, UK, MAY 2022: Female-founded private equity firm PEAL Capital Group (“PEAL”) has acquired the UK’s number one cosmetic training provider, Derma Med Ltd, hereafter the “Company" or “Derma Medical”, the operating name of the Company.

PEAL is pleased to announce it has acquired a majority shareholding in Derma Medical for an undisclosed sum. Derma Medical, a multinational training provider at the forefront of non-surgical aesthetic treatments, equips medical professionals with recognised qualifications in non-invasive injectable cosmetic procedures. In an industry where science meets art, the Derma Medical courses bring new skills and techniques to medical practitioners across the globe.

Karen O'Mahony (Managing Partner) and Tara Mandal (Partner & COO), PEAL Capital Group's philosophy is to acquire controlling stakes in companies with established business models, well-developed products and services and with corporate cultures that hold diversity and inclusion at their very core. PEAL uses a hands-on, proactive approach to reposition their portfolio companies for accelerated growth.

Derma Medical has UK-wide training covering London, Birmingham, Manchester, and Edinburgh, as well as international training academies in Sydney, Brisbane, Melbourne, and Perth (Australia), Stockholm (Sweden) and Dubai (UAE), which attract delegates from around the world.

The global facial injectables market is projected to grow from $4.77 billion in 2021 to $9.07 billion in 2028 at a CAGR of 9.6% in the forecast period, 2021-2028 (Fortune, 2021). Derma Medical is a leading provider of training in this field, offering medical professionals and those registered with professional statutory and regulatory bodies (PSRBs), such as the General Medical Council (GMC), Nursing and Midwifery Council (NMC), General Dental Council (GDC) and General Pharmaceutical Council (GPhC) with recognised qualifications. 

The Company’s growth over the previous five years has been exceptional but the next phase of global expansion requires an injection of operational expertise that the Company have found in PEAL Capital Group. PEAL’s experience in repositioning companies coupled with innovative thinking will aid the international expansion of the enterprise and take the Company to the next level of growth. 

PEAL Capital Group would like to thank PwC, Silicon Valley Bank, Rosetta Tax, Locke Lord, McCann FitzGerald, Waystone, SEI, Ince, Kroll & RWT Growth (who ably represented the vendors on this deal) for their support on this transaction. They say it takes a village to raise a child – we estimate that it took the input of at least 100 dedicated professionals to close out this deal.

Karen O'Mahony, Founder and Managing Partner of PEAL Capital Group, commented, "We are thrilled to partner with Dr Zack Ally, Dr Sanah Qasem and the talented, hardworking and innovative team who have turned Derma Medical into the UK's most reputable and recognised brand in aesthetic procedure training for medical professionals. PEAL invests in high-quality companies with diverse management teams, and this is perfectly exemplified in Derma Medical. Every PEAL deal begins with a 100-day plan and I am pleased to report that the progress of this plan has already exceeded our expectations.”

Dr Amrit Thiara, the CEO of Derma Medical Ltd, added, "At every level of the company I feel proud to be a part of the Derma Med team and what it can do. From the trainers and coordinators who run the courses on the day, to the marketing, sales, finance and operations teams who put everything in place to ensure their success, Derma Med is the best team in the world. I am delighted to work with PEAL to grow Derma Medical into a global brand."

bottom of page